These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 7904561

  • 1. Radioiodinated somatostatin analogue RC-160: preparation, biological activity, in vivo application in rats and comparison with [123I-Tyr3]octreotide.
    Breeman WA, Hofland LJ, Bakker WH, van der Pluijm M, van Koetsveld PM, de Jong M, Setyono-Han B, Kwekkeboom DJ, Visser TJ, Lamberts SW.
    Eur J Nucl Med; 1993 Nov; 20(11):1089-94. PubMed ID: 7904561
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.
    Bakker WH, Krenning EP, Reubi JC, Breeman WA, Setyono-Han B, de Jong M, Kooij PP, Bruns C, van Hagen PM, Marbach P.
    Life Sci; 1991 Nov; 49(22):1593-601. PubMed ID: 1658516
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount.
    de Jong M, Breeman WA, Bernard BF, van Gameren A, de Bruin E, Bakker WH, van der Pluijm ME, Visser TJ, Mäcke HR, Krenning EP.
    Eur J Nucl Med; 1999 Jul; 26(7):693-8. PubMed ID: 10398816
    [Abstract] [Full Text] [Related]

  • 6. Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
    De Jong M, Bakker WH, Breeman WA, Bernard BF, Hofland LJ, Visser TJ, Srinivasan A, Schmidt M, Béhé M, Mäcke HR, Krenning EP.
    Int J Cancer; 1998 Jan 30; 75(3):406-11. PubMed ID: 9455802
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
    Ur E, Bomanji J, Mather SJ, Britton KE, Wass JA, Grossman AB, Besser GM.
    Clin Endocrinol (Oxf); 1993 May 30; 38(5):501-6. PubMed ID: 8101146
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D, Béhé M, Walter MA, Chen J, Powell P, Mikolajczak R, Mäcke HR.
    J Nucl Med; 2005 Sep 30; 46(9):1561-9. PubMed ID: 16157541
    [Abstract] [Full Text] [Related]

  • 15. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.
    Wild D, Schmitt JS, Ginj M, Mäcke HR, Bernard BF, Krenning E, De Jong M, Wenger S, Reubi JC.
    Eur J Nucl Med Mol Imaging; 2003 Oct 30; 30(10):1338-47. PubMed ID: 12937948
    [Abstract] [Full Text] [Related]

  • 16. The somatostatin receptor-targeted radiotherapeutic [90Y-DOTA-DPhe1, Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours.
    Stolz B, Weckbecker G, Smith-Jones PM, Albert R, Raulf F, Bruns C.
    Eur J Nucl Med; 1998 Jul 30; 25(7):668-74. PubMed ID: 9662587
    [Abstract] [Full Text] [Related]

  • 17. Internalization of [DOTA degrees,125I-Tyr3]Octreotide by somatostatin receptor-positive cells in vitro and in vivo: implications for somatostatin receptor-targeted radio-guided surgery.
    Hofland LJ, Breeman WA, Krenning EP, de Jong M, Waaijers M, van Koetsveld PM, Mäcke HR, Lamberts SW.
    Proc Assoc Am Physicians; 1999 Jul 30; 111(1):63-9. PubMed ID: 9893158
    [Abstract] [Full Text] [Related]

  • 18. [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.
    Siehler S, Seuwen K, Hoyer D.
    Eur J Pharmacol; 1998 May 08; 348(2-3):311-20. PubMed ID: 9652348
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and characterisation of [90Y]-Bz-DTPA-oct: a yttrium-90-labelled octreotide analogue for radiotherapy of somatostatin receptor-positive tumours.
    Smith-Jones PM, Stolz B, Albert R, Ruser G, Briner U, Mäcke HR, Bruns C.
    Nucl Med Biol; 1998 Apr 08; 25(3):181-8. PubMed ID: 9620621
    [Abstract] [Full Text] [Related]

  • 20. Use of isotope-labeled somatostatin analogs for visualization of islet cell tumors.
    van Eyck CH, Bruining HA, Reubi JC, Bakker WH, Oei HY, Krenning EP, Lamberts SW.
    World J Surg; 1993 Apr 08; 17(4):444-7. PubMed ID: 8395748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.